Design and Synthesis of Novel Arylpiperazine Derivatives Containing the Imidazole Core Targeting 5-HT2A Receptor and 5-HT Transporter-Reference-Cited by-同舟云学术

Design and Synthesis of Novel Arylpiperazine Derivatives Containing the Imidazole Core Targeting 5-HT2A Receptor and 5-HT Transporter

Published:2011-08-23 Issue:18 Volume:54 Page:6305-6318
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Seo Hee Jeong¹,Park Eun-Jung¹,Kim Min Ju¹,Kang Suk Youn¹,Lee Suk Ho¹,Kim Hyun Jung¹,Lee Ki Nam¹,Jung Myung Eun¹,Lee MinWoo¹,Kim Mi-Soon¹,Son Eun-Jung¹,Park Woo-Kyu²,Kim Jeongmin¹,Lee Jinhwa¹

Affiliation:

1. Research Center, Green Cross Corporation, 303 Bojeong-dong, Giheung-gu, Yongin 446-770, Korea

2. Pharmacology Research Center, Korea Research Institute of Chemical Technology, 100 Jang-Dong, Yuseong-Gu, Daejeon 305-343, Korea

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm200682b

Reference41 articles.

1. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

2. Global Burden of Disease and Injury Series;Murray C. J. L.,1996

3. Mental Health: New Understanding, New Hope; Fact Sheet No. 265.The World Health Report 2001;World Health Organization:Geneva, 2001.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Profound Insight into the Structure-activity Relationship of Ubiquitous Scaffold Piperazine: An Explicative Review;Medicinal Chemistry;2024-01

2. Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure–Activity Relationship Studies;Pharmaceutics;2023-08-26

3. Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry;Molecules;2023-01-13

4. Development of MAO-A and 5-HT_2AR Dual Inhibitors with Improved Antidepressant Activity;Journal of Medicinal Chemistry;2022-09-29

5. A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders;Current Drug Targets;2022-07